CDC Website CDC Website

To Join the NPIN community or

You are here

Commercial Organizations

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)

NPIN admin's picture

This Funding Opportunity Announcement encourages developmentally tailored research focused on adolescents and emerging adults as it relates to HIV prevention and treatment. Exploratory research is encouraged to incorporate recent advances in adolescent and young adult developmental research to better understand HIV prevention and care of this heterogeneous population. PA-18-651 uses the R01 grant mechanism, PA-18-652 uses the R21 mechanism, while PA-18-653 uses the R34 mechanism.

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional)

NPIN admin's picture

This Funding Opportunity Announcement encourages developmentally tailored research focused on adolescents and emerging adults as it relates to HIV prevention and treatment. Research is encouraged to incorporate recent advances in adolescent and young adult developmental research to optimize outcomes in HIV prevention and care research for this heterogeneous population. PA-18-651 uses the R01 grant mechanism, PA-18-652 uses the R21 mechanism, while this FOA uses the R34 mechanism.

Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)

NPIN admin's picture

This Funding Opportunity Announcement (FOA) invites applications for innovative basic and translational research projects examining HIV infection, persistence, and comorbidities as they relate to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and consistent with the scientific priorities outlined by the NIH Office of AIDS Research (OAR) in NOT-OD-15-137.

Basic Research on HIV Persistence (R01)

NPIN admin's picture

Grant Amount: NIH intends to fund an estimate of 8 awards, corresponding to a total of $3.5 million, for fiscal year 2015. The purpose of this initiative is to invite applications that address basic aspects of the persistence of HIV or Simian immunodeficiency virus (SIV) infection in individuals or animals receiving highly active anti-retroviral therapy (HAART). It is expected that applications supported under this FOA will involve at least one of the following areas of study: cellular, structural or systems biology host and viral genetics, immunology, or virology.

Pages

Subscribe to RSS - Commercial Organizations